tiprankstipranks
Trending News
More News >
Context Therapeutics (CNTX)
NASDAQ:CNTX
US Market

Context Therapeutics (CNTX) Income Statement

Compare
187 Followers

Context Therapeutics Income Statement

Last quarter (Q3 2025), Context Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Context Therapeutics's net income was $-9.69M. See Context Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 29.92M$ 25.07M$ 15.38M$ 10.53M$ 2.57M
Depreciation and Amortization
$ 10.88K$ 12.04K$ 9.27K$ 0.00$ 0.00
EBITDA
$ -29.91M$ -25.06M$ -14.87M$ -10.39M$ -2.57M
Operating Income
$ -29.92M$ -25.07M$ -15.38M$ -10.53M$ -2.57M
Other Income/Expenses
$ 3.20M$ 1.11M$ 545.26K$ 68.95K$ 9.22M
Pretax Income
$ -26.73M$ -23.96M$ -14.84M$ -10.46M$ 6.64M
Net Income
$ -26.73M$ -23.96M$ -14.84M$ -10.46M$ 6.64M
Per Share Metrics
Basic EPS
$ -0.46$ -1.50$ -0.93$ -3.69$ 0.61
Diluted EPS
$ -0.46$ -1.50$ -0.93$ -3.69$ -0.80
Weighted Average Shares Outstanding
58.42M 15.97M 15.97M 2.83M 10.96M
Weighted Average Shares Outstanding (Diluted)
58.42M 15.97M 15.97M 2.83M 10.96M
Currency in USD

Context Therapeutics Earnings and Revenue History